The NOrwegian Tennis Elbow (NOTE) Study
The Feasibility of Heavy-slow Resistance Training, Radial Extracorporeal Shockwave Therapy (rESWT) and Information and Advice. The NOrwegian Tennis Elbow (NOTE) Study
1 other identifier
interventional
100
1 country
1
Brief Summary
Trial Design: The Norwegian Tennis Elbow (NOTE) study is a single-centre; three-armed, feasibility randomised controlled trial. Aim: The primary aim of this study is to pilot the methods proposed to conduct a definite RCT study. Objectives:
- Measure the process of recruitment.
- Measure intervention adherence and acceptability.
- Measure outcome measure retention rate and completeness. The Patient-Rated Tennis Elbow Evaluation (PRTEE) will be used as the primary outcome measure. Intervention: Patients will be randomised to either: 1) Heavy slow resistance training (HSR), 2) Radial extracorporeal shock wave therapy (rESWT) or 3) Information and advice. Follow-up will be after 3 and 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 16, 2021
CompletedFirst Posted
Study publicly available on registry
March 18, 2021
CompletedStudy Start
First participant enrolled
August 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2023
CompletedMarch 5, 2024
March 1, 2024
2.1 years
February 16, 2021
March 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
The process of recruitment
Criteria for success is that \>75 percent of patients should be eligible for randomization, \>90% should be willing to be randomized, recruitment rate should be 3.75 participants per month.
2 year
Intervention adherence (appointments)
Criteria for success is that 90 percent meets to appointments (Either physically or tele)
3 months
Intervention adherence (training sessions)
In the HSR group ≥ 30 training sessions should be completed within 12 weeks,
3 months
Intervention acceptability and understandability
≥ 10/20 within each group should rate the treatment ≥+3 "acceptable" and ≥ 10/20 within each intervention group should rate the treatment ≥+3 "understandable"
3 months
Retention and completeness of patient-reported outcome measures
The retention of completed patient-reported outcome measures (i.e. PRTEE, Quick DASH, EQ-5D-5L should be \>75 percent.
6 months
Secondary Outcomes (8)
The Patient-Rated Tennis Elbow Evaluation (PRTEE)
6 months
Disabilities of the Arm, Shoulder and Hand Outcome Measure (Quick-DASH)
6 months
The 5-level EQ-5D (EQ-5D-5L)
6 months
The 5-level EQ-5D (EQ-5D-5L) VAS (EQ VAS)
6 months
Pain free grip strength
3 months
- +3 more secondary outcomes
Study Arms (3)
Heavy Slow Exercise
EXPERIMENTALOne dedicated physiotherapist will supervise and instruct the exercise program on an individual basis. If the patient doesn't have access to a dumbbell, it will be offered free rental from the physiotherapy ward. Follow-up on the exercises will be scheduled as needed and tele rehabilitation will be offered as an option. Additionally to HSR exercises, participants will be instructed to perform daily stretches of the forearm.
Extracorporeal Shock wave therapy
ACTIVE COMPARATORThe patients will receive rESWT (SwissDolodClast/EMS) once a week for three sessions. The treatment will be given by a physiotherapist trained in using rESWT. The rESWT is given on the ECRB tendon insertion area.
Information and advice
ACTIVE COMPARATORThe information and advice group are given a single face-to-face session with a physiotherapist, lasting up to 60 minutes.
Interventions
* Load magnitude: A dumbbell as heavy as possible within the given repetitions and sets. * Number of repetitions: week 1: 15 reps, Week 2-3: 12 reps, Week 4-5: 10 reps, Week 6-8: 8 reps, Week 9-12: 6 reps * Number of sets: 3 * Rest between sets: 2 - 3 min. * Number of exercise interventions: 2 * Duration of experimental period: 12 weeks * Fractional and temporal distribution of the contraction modes per repetition and duration of one repetition: 3s concentric, 2s isometric: while change concentric/eccentric phase, 3s eccentric. * Rest in-between repetitions: No * Range of motion: Full range of motion * Intervention frequency: 3 times a week, with minimum 48 h recovery time in-between.
Two thousand impulses of shock waves are applied to the painful tendon, with a pressure between 1.5 and 3.0 bar (depending on what the patient tolerates). We use a power hand piece that provides energy of 0.01-0.35 mJ/mm2
Information and advice are based on assessment and will comprise the standardized oral and written information. Participants will be educated regarding pain during and after activities and encouraged to be physically active. With only one session, there is great reliance on self-management. Thus, information and advice are made available through a handout.
Eligibility Criteria
You may qualify if:
- Ability to fill in the questionnaires (understand oral and written Norwegian)
- Clinically diagnosed tennis elbow provoked by at least two of: Pain on pressure of the common extensor origin, Pain during power grip, Resisted wrist extension (Tomsen test), Resisted third finger extension (Maudsley´s test), Stretching of the extensors (Mill´s test)
You may not qualify if:
- Patients With significant Language issues (does not understand oral or written Norwegian
- Contraindications to ESWT (pregnancy, coagulation disturbance, connective tissues disease, epilepsy, use og pacemaker)
- Suspicion of other serious illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Oslo University Hospital
Oslo, 0450, Norway
Related Publications (7)
Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, Lancaster GA; PAFS consensus group. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ. 2016 Oct 24;355:i5239. doi: 10.1136/bmj.i5239.
PMID: 27777223BACKGROUNDBeaton DE, Wright JG, Katz JN; Upper Extremity Collaborative Group. Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Joint Surg Am. 2005 May;87(5):1038-46. doi: 10.2106/JBJS.D.02060.
PMID: 15866967BACKGROUNDMacdermid J. Update: The Patient-rated Forearm Evaluation Questionnaire is now the Patient-rated Tennis Elbow Evaluation. J Hand Ther. 2005 Oct-Dec;18(4):407-10. doi: 10.1197/j.jht.2005.07.002. No abstract available.
PMID: 16271687BACKGROUNDSlade SC, Dionne CE, Underwood M, Buchbinder R. Consensus on Exercise Reporting Template (CERT): Explanation and Elaboration Statement. Br J Sports Med. 2016 Dec;50(23):1428-1437. doi: 10.1136/bjsports-2016-096651. Epub 2016 Oct 5.
PMID: 27707738BACKGROUNDMokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, Bouter LM, de Vet HC. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010 May;19(4):539-49. doi: 10.1007/s11136-010-9606-8. Epub 2010 Feb 19.
PMID: 20169472BACKGROUNDHerdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.
PMID: 21479777BACKGROUNDSveinall H, Brox JI, Engebretsen KB, Hoksrud AF, Roe C, Johnsen MB. Heavy slow resistance training, radial extracorporeal shock wave therapy or advice for patients with tennis elbow in the Norwegian secondary care: a randomised controlled feasibility trial. BMJ Open. 2024 Dec 20;14(12):e085916. doi: 10.1136/bmjopen-2024-085916.
PMID: 39806585DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Håkon Sveinall, PT
Oslo University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 16, 2021
First Posted
March 18, 2021
Study Start
August 23, 2021
Primary Completion
September 13, 2023
Study Completion
December 20, 2023
Last Updated
March 5, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Beginning 9 months and ending 36 months following article publication
- Access Criteria
- Researches who provide a methodologically sound proposal
Data are available upon reasonable request